Drug News: Finacea, FluMist, IntanzaFinacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Clinical Notes: Canadian testicular cancer guidelinesGuidelines developed on diagnosis, management of germ cell testicular cancer. Other opportunities enabling expanded scopes of practice Beyond the provision of prescriptive privileges. Medication Forum: SGLT2 inhibitors for type 2 diabetes The potential role of SGLT2 inhibitors in the management of type 2 diabetes. Editorial: How do you like your innovation? In these uncertain times, be open to new ideas, wherever they originate. Research Highlights: Drug-eluting stents - duration of dual antiplatelet therapy Percutaneous coronary intervention is a procedure used to treat the stenotic coronary arteries found in coronary heart disease. Abrupt Stop: Discontinuation syndrome Managing discontinuation syndrome associated with psychoactive medications. Celiac disease: the stealthy robber of health There are many myths and misconceptions surrounding celiac disease. Mapping out this year’s pharmacy trends Our annual Trends & Insights Survey of Retail Pharmacists paints a picture of pharmacy practice amidst volatility. Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. First Previous 3440 3441 3442
